Literature DB >> 11260865

Clinicopathological significance of fibrotic capsule formation around liver metastasis from colorectal cancer.

R Lunevicius1, H Nakanishi, S Ito, K Kozaki, T Kato, M Tatematsu, K Yasui.   

Abstract

PURPOSE: The fibrous capsule around hepatocellular carcinoma is well known to be an indicator of a good prognosis. However, the fibrotic stromal response in the liver to a metastatic tumor remains unclear. PATIENTS AND METHODS: In order to clarify the prevalence of fibrotic capsular formation around liver metastases as well as the prognostic and biological significance of the fibrotic capsule, 69 colorectal cancer patients, who underwent radical hepatectomy due to liver metastases, were investigated using immunohistochemical methods.
RESULTS: Encapsulated metastases as defined by a thick fibrotic band surrounding the entire surface of a metastasis were detected in 20% of the cases. The rate of initial recurrence in the remnant liver, which is a strong indicator for poor prognosis of colorectal liver metastasis, was significantly lower in the encapsulated metastasis group as compared with the non-encapsulated metastasis group. Proliferating fibroblastic cells in the capsule were myofibroblasts positively stained for alpha-smooth muscle actin (alpha-SMA) and they deposited dense extracellular matrices rich in collagen Type 1 in the layer of the inner half and secreted MMP-1, MMP-2, and TIMP-1 in the layer of the outer half of the capsule. Activation of alpha-SMA positive hepatic stellate cells (HSC) was also observed in the liver parenchyma adjacent to metastases.
CONCLUSIONS: The results indicate that fibrotic capsular formation is associated with a lower rate of initial local recurrence in the remnant liver, and that the capsule may serve as a mechanical and chemical barrier to local invasion by metastatic tumor cells. Proliferating stromal cells in the capsule are myofibroblasts, probably derived from HSC activated by colorectal liver metastasis in the liver parenchyma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11260865     DOI: 10.1007/s004320000199

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  25 in total

1.  The histological growth pattern of colorectal cancer liver metastases has prognostic value.

Authors:  Gert G Van den Eynden; Nigel C Bird; Ali W Majeed; Steven Van Laere; Luc Y Dirix; Peter B Vermeulen
Journal:  Clin Exp Metastasis       Date:  2012-04-03       Impact factor: 5.150

2.  Growth pattern of colorectal liver metastasis as a marker of recurrence risk.

Authors:  R L Eefsen; P B Vermeulen; I J Christensen; O D Laerum; M B Mogensen; H C Rolff; G G Van den Eynden; G Høyer-Hansen; K Osterlind; B Vainer; M Illemann
Journal:  Clin Exp Metastasis       Date:  2015-03-31       Impact factor: 5.150

3.  A solid lipid nanoparticle formulation of 4-(N)-docosahexaenoyl 2', 2'-difluorodeoxycytidine with increased solubility, stability, and antitumor activity.

Authors:  Solange A Valdes; Riyad F Alzhrani; Andres Rodriguez; Dharmika S P Lansakara-P; Sachin G Thakkar; Zhengrong Cui
Journal:  Int J Pharm       Date:  2019-08-12       Impact factor: 5.875

4.  Collagen type IV, laminin, alpha-smooth muscle actin (alphaSMA), alpha1 and alpha6 integrins expression in the liver with metastases from malignant gastrointestinal tumours.

Authors:  Maya Vladova Gulubova
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

5.  mRNA expression profiles of colorectal liver metastases as a novel biomarker for early recurrence after partial hepatectomy.

Authors:  E P van der Stok; M Smid; A M Sieuwerts; P B Vermeulen; S Sleijfer; N Ayez; D J Grünhagen; J W M Martens; C Verhoef
Journal:  Mol Oncol       Date:  2016-09-20       Impact factor: 6.603

6.  Extended pathology reporting of resection specimens of colorectal liver metastases: the significance of a tumour pseudocapsule.

Authors:  Matthew G Wiggans; Golnaz Shahtahmassebi; Paul Malcolm; Frances McCormick; Somaiah Aroori; Matthew J Bowles; David A Stell
Journal:  HPB (Oxford)       Date:  2012-12-27       Impact factor: 3.647

7.  Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate?

Authors:  Eran Sadot; Bas Groot Koerkamp; Julie N Leal; Jinru Shia; Mithat Gonen; Peter J Allen; Ronald P DeMatteo; T Peter Kingham; Nancy Kemeny; Leslie H Blumgart; William R Jarnagin; Michael I DʼAngelica
Journal:  Ann Surg       Date:  2015-09       Impact factor: 12.969

8.  Stromal fibroblasts in colorectal liver metastases originate from resident fibroblasts and generate an inflammatory microenvironment.

Authors:  Lars Mueller; Freya A Goumas; Marianne Affeldt; Susanne Sandtner; Ursula M Gehling; Silke Brilloff; Jessica Walter; Nadia Karnatz; Katrin Lamszus; Xavier Rogiers; Dieter C Broering
Journal:  Am J Pathol       Date:  2007-10-04       Impact factor: 4.307

9.  Histopathological prognostic factors for colorectal liver metastases: A systematic review and meta-analysis of observational studies.

Authors:  Cássio Virgílio Cavalcante de Oliveira; Gilton Marques Fonseca; Jaime Arthur Pirola Kruger; Evandro Sobroza de Mello; Fabricio Ferreira Coelho; Paulo Herman
Journal:  Histol Histopathol       Date:  2020-11-09       Impact factor: 2.303

10.  How fibrosis influences imaging and surgical decisions in pancreatic cancer.

Authors:  Mert Erkan; Simone Hausmann; Christoph W Michalski; Anna M Schlitter; Alexander A Fingerle; Martin Dobritz; Helmut Friess; Jörg Kleeff
Journal:  Front Physiol       Date:  2012-10-02       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.